Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
CO
CHR. OLESEN PHARMACEUTICALS A/S
aktivCVR 32090168AktieselskabJægersborg Alle 164, 2820 GentofteEngroshandel med medicinalvarer og sygeplejeartikler
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Data quality concern—
Data quality concern
Operating profit
DKK 581k
Latest period
Source details
Source: dk-regnskabsdata-live-32090168-1793944684701
Document: dk-regnskabsdata-32090168-AZxWm6bQz53i_6-1GIjA-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: D0
Unit: U-iso4217-EUR
Net result
DKK 237.4k
Latest period
Source details
Source: dk-regnskabsdata-live-32090168-1793944684701
Document: dk-regnskabsdata-32090168-AZxWm6bQz53i_6-1GIjA-1
XBRL: fsa:ProfitLoss
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: D0
Unit: U-iso4217-EUR
Equity
DKK 1.7m
Equity ratio: 15.4%
Source details
Source: dk-regnskabsdata-live-32090168-1793944684701
Document: dk-regnskabsdata-32090168-AZxWm6bQz53i_6-1GIjA-1
XBRL: fsa:Equity
Period: 01 Oct 2024 - 30 Sept 2025
Technical details
Context: I0
Unit: U-iso4217-EUR
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2019 | — | DKK 475k |
| 2020 | — | DKK 455k |
| 2021 | — | DKK 251k |
| 2022 | — | DKK 465.2k |
| 2023 | — | DKK 421.2k |
| 2024 | — | DKK 70.6k |
| 2025 | — | DKK 237.4k |